ImmuniT Research logo — Pioneering Advances in Immunotherapy with Daily Precision.

ImmuniT Research

Pioneering Advances in Immunotherapy with Daily Precision.

Founded 2017 Series Unknown Biotechnology, Care Economy +2

General Information

Company Name ImmuniT Research
Founded Year 2017
Industries Biotechnology, Care Economy, Health Care +1
Funding Stage Series Unknown
Social

Get notified when ImmuniT Research moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ImmuniT Research

ImmuniT Research is a biotechnology startup founded in 2017 that focuses on pioneering advances in immunotherapy with daily precision. They develop clinical efficacy evaluations for immune checkpoint inhibitors and conduct immunological analysis using the BD LSRFortessa X-20 on a daily basis. Their research is centered around novel immunotherapy.

The company's latest investment was a Venture Round at 23 December 2019 led by DOJIN CAPITAL. ImmuniT Research operates in the Biotechnology, Health Care, and Information Technology industries. Despite not having a specified headquarters, their focus on cutting-edge immunotherapy research and recent investment from DOJIN CAPITAL positions them as an emerging player in the biotech startup landscape.

Taxonomy: Immunotherapy, Clinical Efficacy, Research, Immunological Analysis, BD LSRFortessa X-20, Immune Check Inhibitors, Precision Medicine, Biomedical Research, Innovation, Immunological Research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
23 Dec 2019

ImmuniT Research Alternatives & Competitors

ImmuniT Research vs
CeMM
CeMM Austria

The Research Center for Molecular Medicine of the Austrian Academy of Sciences.

301 employees
ImmuniT Research vs
RemedyBio
RemedyBio Ireland

Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and di...

Series Unknown
7 employees
Biotechnology, Health and Wellness
ImmuniT Research vs

Your Research Partner....

15 employees
Biotechnology

FAQ About ImmuniT Research

Pioneering Advances in Immunotherapy with Daily Precision.
ImmuniT Research was founded in 2017.
ImmuniT Research operates in the following industries: Biotechnology, Care Economy, Health Care, Information Technology.
ImmuniT Research has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to ImmuniT Research include CeMM, RemedyBio, African Biosciences Ltd, biosyn Arzneimittel GmbH, Immuquest. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ImmuniT Research and CeMM are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ImmuniT Research and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy